Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
To determine the safety and efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in subjects with atherosclerotic de novo or restenotic lesions in the native common iliac artery and/or native external iliac artery.
Full description
The MOBILITY study was a prospective, non-randomized, two-arm, multi-center study. The 2 arms (Omnilink Elite arm and Absolute Pro arm) were designed to independently assess the safety and effectiveness of the 2 devices used in this study.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Clinical Inclusion Criteria:
Angiographic Inclusion Criteria
Clinical Exclusion Criteria
Angiographic Exclusion Criteria
Primary purpose
Allocation
Interventional model
Masking
153 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal